Open AccessThe Treatment Based on Ruxolitinib and Amphotericin B is Effective for Relapsed Leishmaniasis-Related Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
Author(s) -
Tingting Cui,
Jingshi Wang,
Zhao Wang
Publication year - 2022
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s384628
Subject(s) - medicine , hemophagocytic lymphohistiocytosis , ruxolitinib , amphotericin b , immunology , leishmaniasis , etiology , leishmania , visceral leishmaniasis , antifungal , dermatology , bone marrow , disease , myelofibrosis , parasite hosting , world wide web , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom